Black Rock Inc. Milestone Pharmaceuticals Inc. Transaction History
Black Rock Inc.
- $4.35 Trillion
- Q2 2024
A detailed history of Black Rock Inc. transactions in Milestone Pharmaceuticals Inc. stock. As of the latest transaction made, Black Rock Inc. holds 4,971,344 shares of MIST stock, worth $9.74 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
4,971,344
Previous 4,971,344
-0.0%
Holding current value
$9.74 Million
Previous $8.9 Million
26.25%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding MIST
# of Institutions
51Shares Held
16.8MCall Options Held
341KPut Options Held
70.3K-
Rtw Investments, LP New York, NY2.51MShares$4.91 Million0.03% of portfolio
-
Propel Bio Management, LLC Los Angeles, CA1.45MShares$2.85 Million1.35% of portfolio
-
Alta Fundamental Advisers LLC New York, NY1.43MShares$2.8 Million0.56% of portfolio
-
Bml Capital Management, LLC Zionsville, IN1.14MShares$2.23 Million0.74% of portfolio
-
Morgan Stanley New York, NY969KShares$1.9 Million0.0% of portfolio
About Milestone Pharmaceuticals Inc.
- Ticker MIST
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 30,010,900
- Market Cap $58.8M
- Description
- Milestone Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of cardiovascular medicines. The company is developing etripamil, a novel channel blocker, which is in Phase III clinical trial for the treatment of paroxysmal supraventricular tachycardia in the United States and Canada; and Phase II cl...